Results 331 to 340 of about 95,583 (387)
Use of sodium-glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020. [PDF]
Hare MJL+4 more
europepmc +1 more source
Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulation. [PDF]
Tang H+7 more
europepmc +1 more source
Fluid Overload in Cardiorenal Medicine: From Bench to Bedside.
Cobo Marcos M+2 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Diabetes, obesity and metabolism, 2021
To evaluate whether sodium‐glucose cotransporter‐2 (SGLT2) inhibition reduces cellular senescence in the kidney and to investigate the molecular pathways involved in the renoprotective effect.
Mi Na Kim, Joon Ho Moon, Y. Cho
semanticscholar +1 more source
To evaluate whether sodium‐glucose cotransporter‐2 (SGLT2) inhibition reduces cellular senescence in the kidney and to investigate the molecular pathways involved in the renoprotective effect.
Mi Na Kim, Joon Ho Moon, Y. Cho
semanticscholar +1 more source
Current Opinion in Cell Biology, 1996
Recent studies of cloned mammalian sodium cotransporters in heterologous systems have revealed that these integral membrane proteins serve multiple functions as cotransporters, uniporters, channels and water transporters. Some progress has been gained in understanding their secondary structure, but information on helical bundling and tertiary structure
E M, Wright+3 more
openaire +2 more sources
Recent studies of cloned mammalian sodium cotransporters in heterologous systems have revealed that these integral membrane proteins serve multiple functions as cotransporters, uniporters, channels and water transporters. Some progress has been gained in understanding their secondary structure, but information on helical bundling and tertiary structure
E M, Wright+3 more
openaire +2 more sources